Social Media Press Releases

RSS

Showing Press Releases with Tag: antibodies

6/23/2010

POSITION ON BIOSIMILARS

» read more
6/01/2009

HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

» read more
10/24/2008

MedImmune to Present Nine Abstracts on RSV and Influenza at 48th Annual ICAAC/46th Annual IDSA Meeting

» read more
12/07/2007

AstraZeneca Presents its Global Biologics Organisation, MedImmune, at 2007 Analyst and Investor R&D Day

» read more
10/15/2007

MedImmune and Crucell Announce Collaboration to Develop New Antibodies for the Treatment and Prevention of Hospital-Acquired Bacterial Infection

» read more
10/09/2007

Data from MedImmune Infectious Disease Clinical Programs Presented at European Society for Paediatric Research Annual Meeting

» read more
7/23/2007

MedImmune Announces Interim Phase 1 Study Results for Potential Asthma Therapy

» read more
5/24/2007

MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations

» read more
5/02/2007

Pediatric Academic Societies’ Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV

» read more
4/23/2007

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion

» read more
3/23/2007

MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis

» read more
12/28/2006

MedImmune In-Licenses Novel Inflammatory Disease Target

» read more
12/19/2006

MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With Biowa

» read more
12/18/2006

MedImmune Completes Sale of CytoGam(R)

» read more
12/06/2006

MedImmune Reconfirms 2009 Financial Targets of $2 Billion in Revenues and $2.00 in Earnings Per Diluted Share, Excluding Share-Based Compensation Expense, at 2006 Analyst Day

» read more